Name | apraclonidine hydrochloride |
---|---|
Synonyms |
UNII-D2VW67N38H
Iopidine ophthalmic solution MFCD00135922 2-(4-Amino-2,6-dichlorophenylimino)imidazolidine 2-[(4-amino-2,6-dichlorophenyl)imino]imidazolidine monohydrochloride APRACLONIDINE HYDROCHLORIDE ALO-2145 2,6-dichloro-1-N-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine,hydrochloride p-aminoclonidine hydrochloride NC 14 hydrochloride 2-[(2,6-dichloro-4-aminophenyl)imino]imidazolidine hydrochloride p-aminoclonidine mono hydrochloride Apraclonidine HCl |
Description | Apraclonidine hydrochloride (ALO 2145), a selective α2 and weak α1 receptor agonist activity, effectively lowers intraocular pressure (IOP) in human eyes. Apraclonidine hydrochloride is a topical ophthalmic solution and has the ability to elevate the eye lid[1][2]. |
---|---|
Related Catalog | |
In Vitro | Apraclonidine hydrochloride (ALO 2145) is more commonly used topically for glaucoma, as it penetrates the cornea and blood-brain barrier to a lesser extent and, thus, has fewer adverse systemic effects[2]. |
In Vivo | Apraclonidine hydrochloride (ALO 2145) is effective in animal models of elevated IOP as well as glaucoma in humans. The ocular hypotensive effects of Apraclonidine are usually attributed to reduced aqueous humor synthesis and vasoconstrictor actions at the anterior segment branches of the ophthalmic artery[2]. |
References |
[1]. Wijemanne S, et al. Apraclonidine in the treatment of ptosis. J Neurol Sci. 2017;376:129‐132. |
Density | 1.63 g/cm3 |
---|---|
Boiling Point | 395.5ºC at 760 mmHg |
Melting Point | >230ºC |
Molecular Formula | C9H11Cl3N4 |
Molecular Weight | 281.56900 |
Flash Point | 193ºC |
Exact Mass | 280.00500 |
PSA | 62.44000 |
LogP | 3.16730 |
Storage condition | 2-8°C |
Stability | Moisture Sensitive |
Water Solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 1.4 mg/mL Solutions may be stored for several days at 4?#x00b0;C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
![]() ![]() GHS06, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H300-H370 |
Precautionary Statements | Missing Phrase - N15.00950417-P308 + P311 |
Target Organs | Cardio-vascular system |
Hazard Codes | T: Toxic; |
Risk Phrases | R23/24/25 |
Safety Phrases | 22-36/37/39-45 |
RIDADR | UN 2811 |
WGK Germany | 3 |
Packaging Group | III |
Hazard Class | 6.1(b) |
HS Code | 2933290090 |
HS Code | 2933290090 |
---|---|
Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |